
Mutual funds bet big on healthcare stocks after Trump's tariff pause. Is the danger really over?
Mutual funds with highest exposure in health stocks
Returns snapshot
Outlook
(You can now subscribe to our
(You can now subscribe to our ETMarkets WhatsApp channel
Donald Trump 's 90-day pause on reciprocal tariffs announced on April 9, 2025, brought much-needed stability to stock markets and lifted sentiment in the pharma and healthcare sectors, which had been clouded by uncertainty.The pharmaceutical sector found itself in a unique position, having received exemptions in the initial tariff announcements which kicked-in on April 2, though no clarity on what lay ahead. Between April 2 and April 9, the Nifty Healthcare index had declined by over 3%, or nearly 1,300 points.However, the Nifty Healthcare index staged a strong rebound following the pause, rising 7% or around 2,650 points over the remaining 12 trading sessions of the month. This recovery was accompanied by notable institutional activity, with mutual funds increasing their holdings in 11 healthcare stocks in April compared to March.Healthcare was also among the sectors where MF ownership was higher by over 1% versus the sector's weight in the BSE 200 index.According to a Motilal Oswal report, 17 funds were over-owned and MFs weight on the sector stood at 7.6% in April, behind private banks (18.9%), technology (8.3%) and automobiles (8%). Meanwhile, the healthcare sector in BSE 200 stands at 5.4%, the report revealed.Highest MoM buying of 11.43% in April was seen in midcap stock Syngene International . It was followed by Glenmark Pharmaceuticals Dr. Reddy's Laboratories and Laurus Labs where mutual funds added stake by 7.63%, 6.05% and 3.85%, respectively.Others like Lupin, Aurobindo Pharma, Divi's Laboratories, Sun Pharmaceutical Industries, Abbott India, Ipca Laboratories and Biocon also saw mutual fund action towards the buying side.Nine healthcare stocks also went under the hammer and saw a sell-off. These were Zydus Lifesciences Torrent Pharmaceuticals , Max Healthcare Institute, Mankind Pharma, Granules India, Fortis Healthcare, Cipla, Apollo Hospitals Enterprise and Alkem Laboratories.MF selling was highest in Torrent Pharma and Zydus Lifesciences at 8.34% and 4.87%, respectively. The next in the pecking order were Granules, Apollo and Mankind where MFs sold 3.89%, 3.64% and 3.61%. The others saw a sell-off between 1.67% and 0.46%.Sumit Bhatnagar, Fund Manager Equity at LIC Mutual Fund said that the healthcare sector often remains resilient due to the essential nature of its services and products and innovations and an aging population continue to drive demand. However, the potential impact of Trump's tariffs on the healthcare sector is a valid concern in his view and tariffs could increase costs for healthcare companies which could affect their profitability. "These increased costs might be passed on to consumers or could lead to reduced margins for healthcare companies," he told ETMarkets.DSP and Quant top the list with holdings of 11.5% and 11.1%, respectively and are followed by Axis MF (10.4%), Mirae (9.7%), HDFC MF (9.1%) and Sundaram MF (8.4%).The lowest holdings are for SBI MF (5.1%), MOFSL (5.5%) and UTI MF (6.1%).Nifty Healthcare index's 1-year returns stand at 17%, outperforming Nifty which has returned 12% in the same period.MFs continued to show trust on Syngene in April despite a 6% drop in share price over a 1-year period. Meanwhile, mutual funds sold shares in laggards Zydus Lifesciences and Alkem which have fallen 14% and 2% in the past 12 months.Divi's remains the best performer in the pack with 60% returns and MFs added stakes in April (1.13%) and March (2%). Glenmark and Laurus, which also saw significant MF action, have returned robust 44% and 36% returns.Lupin, Abbott, Sun Pharma and Biocon have also given double-digit returns in the same period while IPCA, Aurobindo and Dr. Reddy's have delivered single-digit returns.Mutual funds booked partial profits in stocks like Fortis Health, Max Health, Granules, Mankind and Torrent Pharma whose 1-year returns stand in the range of 21% and 56%. Apollo Hospitals has yielded 18% returns while Cipla has been an underperformer with just 6% returns.The sector is again in the eye of the storm as Trump has signed an executive order to bring the prices for prescription (Rx) drugs in line with other developed nations. The order institutes the Most-Favoured-Nation (MFN) price model for drugs as a ceiling which means the US will pay for drugs at the same levels as the lowest paid by other countries."The policy initiatives, if implemented fully, may lead to increased compliance/operational cost for foreign manufacturers, including those in India. We expect generic pharma to continue to underperform due to uncertainty," Nuvama Institutional Equities said in a note. It prefers Ajanta Pharma, Torrent Pharma and Divi's Lab.HDFC Securities sees the generic companies unlikely having any impact, though it expects Sun Pharma with its specialty business in the US, to see some impact of MFN price ceiling for a few of its products. JM Financial sees over 20% growth visibility for hospitals and CDMO for the next 4-5 years. Amongst the hospitals, it likes Max Healthcare, Aster DM and Fortis while Piramal Pharma and One Source in CDMO.However, UBS expects healthcare to outperform Nifty over the next 12-month period as the Zurich-based brokerage reiterated its positive stance on Nifty, seeing an 8% upside with a target of 26,000. In a note of caution on generic pharma export names, it expects earnings downgrades starting in 2HFY26.: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


India Today
7 minutes ago
- India Today
US tariff impact will be temporary, private sector should step up: Chief economist
Chief Economic Advisor V Anantha Nageswaran on Wednesday said US tariffs-related challenges will dissipate in the next one or two quarters, and urged the private sector to do more as the country navigates through other longer-term attributed the growth slowdown in FY25, which saw a deceleration to 6.5 per cent from FY24's 9.2 per cent, to tight credit conditions and liquidity issues. The right agriculture policies can add 25 per cent to real GDP growth, Nageswaran the US tariffs, the CEA said it is the second and third order impacts, which will flow once sectors like gems and jewellery, shrimps and textiles have taken the first order brunt, that will be "more difficult" to tackle. The government is aware of the situation and conversations with the impacted sectors have already begun, Nageswaran said, adding that one will hear from the policymakers in the coming days and weeks, but people have to be speculation on whether US officials will visit India for trade talks later this month as reported, Nageswaran said the upcoming meet in Alaska between US President Donald Trump and his Russian counterpart Vladmir Putin is likely to influence the to spell out any details on the trade negotiations between India and the US, the academic-turned-advisor said things are very fluid at the world stage right now with relations swinging from cooperation to stalemate, and spelled out his expectation of the impact of a 50 per cent US tariff on Indian exports."I do believe that the current situation will ease out in a quarter or two. I don't think that from a long-term picture, the India impact will be that significant but in the short run, there will be some impact," he said no one can guess the exact reasons why President Donald Trump chose to slap the high tariffs on India, wondering if it's the fallout of Operation Sindoor or something even more the CEA said the focus on tariff-related issues should not blind us to more "important challenges", including the impact of artificial intelligence, reliance on one country for critical minerals, and their processing and strengthening of supply exhorted the private sector to do more "as we navigate these longer-term challenges, promising that public policy will play the facilitator's role"."Private sector also has a lot of thinking to do, given the massive strategic challenges we face in the coming years... the private sector also has to think about the long-term rather than the next quarter, which is what might have led to many of the challenges we are currently beginning to face," he said in the comments aimed at India however, did not elaborate on the subject any that the government has allocated money towards the research purposes, he said it is now for the private sector to up their investments in the Indian youth is staring at both physical and health issues arising from excess screen use, consumption of ultra-processed food, etc, which is leading to anxieties and even suicidal thoughts among people, the CEA said, seeking the private sector's help to tackle the welcomed the capital expenditure put in by the private sector in FY26 and data to be released in February next year will attest to the consumption story is "quite healthy", the CEA said, pointing to the data on UPI usage. Specifically on urban consumption, he rued that there is no proper data source to capture services consumption, and added that drawing from listed companies' earnings may also not be the right measure as consumption is moving to the unlisted overall resource mobilisation in the economy is not showing any slackening, the CEA said, asking all to look at banks credit growth, commercial paper issuances, and IPO fundraising China, Nageswaran said "we also need to understand the security dimension and look at the USD 100 billion trade deficit beyond just the number". As a solution, there is a need to diversify the sources of imports and the CEA stressed that the private sector will have a role to play naming China, he said only one country supplies critical minerals, which are essential for semiconductors, artificial intelligence tech, and added that the supply is "critically unstable"."We cannot go from crude oil import dependence to critical minerals and ladders import dependence. Understand that crude oil (sources) at least is more diversified," he said."Indian policy-makers must choose between accepting permanent strategic dependence on adversaries or committing the resources necessary for genuine support to independence," Nageswaran that AI will cause labour displacement, Nageswaran pitched for caution in AI adoption and added that "we will have to choose the areas in which we allow AI to be deployed and harnessed, and also the speed with which we do so".There is a need to create at least 80 lakh new jobs per annum in the next 10–12 years, he added.(Disclaimer: The views, opinions, recommendations, and suggestions expressed by experts/brokerages in this article are their own and do not reflect the views of the India Today Group. It is advisable to consult a qualified broker or financial advisor before making any actual investment or trading choices.)- EndsMust Watch


India Today
an hour ago
- India Today
Slamming 50% Trump tariffs, farmer leader Chaduni urges ban on US firms in India
Haryana farmer leader Gurnam Singh Chaduni has called for a complete ban on American companies operating in India after US President Donald Trump announced steep tariffs on Indian week, Trump signed an Executive Order imposing an additional 25% duty on Indian imports — on top of an earlier 25% hike — citing India's continued purchase of Russian oil. The combined 50% tariff will take effect from August to the move, Bharatiya Kisan Union (Chaduni) chief Gurnam Singh Chaduni said India must "hit back in a similar manner" by targeting US companies. "The US has imposed heavy tariffs on India and India must hit back in a similar way and ban American companies operating on Indian soil," Chaduni told India Today farmer leader argued that many American businesses in India, especially large fast-food and retail chains, earn substantial profits and repatriate them to the US."Why are we allowing this when the US is imposing tariffs on us? We must give a similar reply and ban all these companies," he said. "You travel on highways and one can spot the big food giants of the US spreading their business all over. This must stop," Chaduni farmer leader, who played a prominent role in the 2022 anti-farm laws protests, said the government must take a firm stand to deter future trade pressure from Washington."We cannot allow anyone to dictate things to us like this. If we don't take a stand now, America will continue to do this in the future too and threaten us regularly. The US-based companies should immediately be banned and not allowed to mint money," he demand also comes against the backdrop of a long-standing flashpoint in India–US trade of the contentious issues has been the proposed entry of US companies into India's dairy and agriculture sectors — a move New Delhi has consistently resisted, citing potential threats to farmers' livelihoods and to the country's self-reliance in these key Washington escalating trade tensions through higher tariffs, Chaduni's call to ban US businesses signals growing pressure on the Indian government to respond with stronger retaliatory measures.- EndsMust Watch
&w=3840&q=100)

Business Standard
2 hours ago
- Business Standard
Nvidia, AMD China revenue deal could be model for others, says Bessent
Treasury Secretary Scott Bessent said the recent deal to allow Nvidia Corp. and Advanced Micro Devices Inc. to resume lower-end AI chip sales to China, on the condition they give the US government a 15 per cent cut of the related revenue, could serve as a model for others. 'I think we could see it in other industries over time,' Bessent said Wednesday in a television interview on Bloomberg Surveillance. 'Right now, this is unique, but now that we have the model and the beta test, why not expand it?' Bessent credited President Donald Trump with the 'very unique solution' of allowing Nvidia to expand in China and become a bellwether for Chinese technology, with the US taxpayer getting 'a share of' the reward. The revenue the Treasury receives from the arrangement will go to pay down debt, he said. 'If we could make a substantial debt' repayment, that would then allow for discussions about a program of sending money to taxpayers, he also said. Asked about reporting that China is urging its companies to avoid the Nvidia H20 processors now allowed for its market, Bessent said 'sure, we can discuss that' with the Chinese. 'But it also tells me that they are worried about the Nvidia chips becoming the standard in China.' China Talks On Tuesday, Bessent said that he'd be meeting again with his Chinese counterparts 'within the next two or three months,' speaking on Fox Business. He dismissed the possibility of China emulating other US trading partners in winning tariff relief in return for boosting investments in the US. When asked if China could make pledges worth billions of dollars like Japan, South Korea and the EU have as part of their trade agreements, Bessent said 'my sense is no because a lot of the buyout or the funds from the buyout are going to go to critical industries that we need to reshore and a lot of those need to be reshored away from China.' Whether the industry was semiconductors, rare-earth magnets, pharmaceuticals or steel, 'my sense is that isn't what will happen,' Bessent said in an interview with Fox Business on Tuesday. Tech and AI have been among the most high profile of areas of competition between the world's two biggest economies. President Donald Trump has extended a pause of higher tariffs on Chinese goods for another 90 days into early November, a move that stabilized trade ties between the world's two largest economies while they try to forge an agreement. Chinese companies in sectors such as electric vehicles have opened factories abroad to access new markets, a move that could also help them skirt US tariffs. He also indicated that Washington wanted to see measures from China over an extended period to stem the flow of chemicals used to make fentanyl before lowering duties Trump put in place over the issue. 'We will need to see months, if not quarters, if not a year, of progress on that before I could imagine those tariffs coming down,' he said.